News

Downstream purification makes up over 60% of biologic production costs, a major bottleneck for affordability and profits. Driven by high chromatography costs and supply chain risks, the industry is pursuing technology-led cost reduction via process innovation, CDMO outsourcing, and diversified supply chains. This paper reviews the cost structure and solutions for efficient, stable manufacturing.

This paper reviews three key trends: continuous manufacturing, AI & digital twins, and green materials & circular economy. Their integration is building smarter, more efficient biopharmaceutical factories, delivering more accessible and reliable medicines to patients.

Inside precise stainless steel tanks, cell culture media circulates under intelligent control as real-time data flickers on screens—a microcosm of a multi-billion dollar market. In 2024, the global bioreactor market reached 7,079.1 million and is projected to surpass the 10,083.2 million mark by 2029.

The upstream bioreactor market, covering equipment and key consumables, is the physical foundation of bioprocessing. This article focuses on the technical evolution, market competition, and supply chain of equipment (control systems, sensors) and core consumables (single-use components, media). Through analysis of product categories, technical parameters, supplier strategies, and cost structures, it reveals the inner logic and future direction of this market segment.

This article provides a systematic analysis of the global bioreactor market, covering size, key drivers, technical segments, regional dynamics, and future trends. As critical equipment in biopharmaceuticals, tissue engineering, and food industries, bioreactor demand is intrinsically linked to biotech sector growth. Based on authoritative data, we deconstruct upstream manufacturing and downstream application markets to provide strategic insights for industry stakeholders.

This article explores the core of biopharmaceutical upstream processing: cell culture. It systematically describes mammalian cell culture modes (batch, fed-batch, perfusion), details the seed expansion strategy from cell banks to production bioreactors, and highlights how PAT and QbD frameworks enable lean control over cell growth and protein expression. It provides a comprehensive technical perspective on modern cell culture process development and execution.

This article focuses on the two pillars of upstream bioprocessing: culture media and bioreactors. It analyzes the logic of chemically defined media development and component optimization while comparing bioreactor types (stirred-tank vs. single-use) regarding design, operation, and scale-up. By explaining how these systems maintain the optimal environment for cell growth, it reveals the path to achieving robustness and economic efficiency in upstream processes.

This paper reviews cutting-edge trends and strategies in upstream bioprocessing. It discusses the shift from batch to continuous manufacturing, and how AI, machine learning and automation drive process intelligence. It also addresses new demands from cell and gene therapies and the outlook for green biomanufacturing, outlining the upcoming paradigm shift in upstream bioprocessing.